← SynDRA
CLEMASTINE
SynDRA canonical compound SYN0014227 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HRH1 |
| Mechanism of action | Histamine receptor antagonist |
| Indication | allergic rhinitis | urticaria |
| Disease area | allergy |
All known targets
- HRH1
- ADRA1D
- ADRA2A
- SLC6A3
- SLC6A2
- SLC22A1
- SIGMAR1
- Pgrmc1
- KCNH2
- Htr1b
- HTR6
- HTR2C
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Anti-Allergic Agents
- Antipruritics
- Dermatologic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
- D04A · ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
Cross-references
Synonyms
- meclastine
- clemastine fumarate
- Clemastina
- Clemastin
- HS-592
- NSC-756685
- Clemastinum
- Meclastin
- Meclastine
- Mecloprodin
- Tavegyl
- Tavist
- CLEMASTINE FUMARATE
- Clemastina [INN-Spanish]
- Clemastine [USAN:BAN]
- Clemastinum [INN-Latin]
- Tavegyl (TN)
- Tavist (TN)
- Tavist (*Fumarate*)
- (+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine
- (+)-(2R)-2-[2-[[(R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl]oxy]ethyl]-1-methylpyrrolidine
- (2R)-2-(2-{[(1R)-1-(4-chlorophenyl)-1-phenylethyl]oxy}ethyl)-1-methylpyrrolidine
- (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine
- (2R)-2-{2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl}-1-methylpyrrolidine
- 2(R)-[2-[(1R)-(4-Chlorophenyl)-1-phenyl-ethoxy]ethyl-1-methylpyrrolidine
- 2-(2-(4-Chlor-alpha-methylbenzhydryloxy)ethyl)-1-methylpyrrolidin
- HS 592
- NSC 756685
- CHEBI:3738
- RefChem:56359
- DTXCID502832
- D04AA14
- R06AA04
- HS592
- C21H26ClNO
- MLS002154260
- CLEMASTINE [USAN]
- NCGC00016710-01
Reported adverse events
Look up CLEMASTINE in the interactive SynDRA portal →